Thursday, 21 May 2026
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • House
  • ScienceAlert
  • White
  • VIDEO
  • man
  • Trumps
  • Season
  • star
  • Years
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > Vinay Prasad, SNAP-ed, NIH grants
Health and Wellness

Vinay Prasad, SNAP-ed, NIH grants

Last updated: July 30, 2025 10:20 pm
Share
Vinay Prasad, SNAP-ed, NIH grants
SHARE

The world of health and medicine is constantly evolving, with new developments and discoveries happening every day. From changes in public health policies to the latest research on substance use disorders, there is always something new to learn and explore in the field of healthcare.

One recent headline that caught the attention of many was the departure of Vinay Prasad from the FDA. This unexpected move raised questions and sparked discussions about the future direction of the agency. At the same time, the Trump administration made headlines by blocking the NIH from awarding research grants and contracts, causing concern among researchers and scientists.

One major blow to public health was the decision to end the SNAP-Ed program, a vital initiative aimed at educating low-income individuals about healthy eating habits. Despite its proven success, the program was deemed “wasted” by the House Committee on Agriculture, leading to its termination. This decision was met with criticism from public health experts who recognized the importance of nutrition education in combating obesity and improving overall health.

On the topic of substance use disorders, a recent federal survey revealed interesting trends in American habits. While tobacco use and binge drinking have decreased, the use of marijuana has increased significantly. These findings shed light on changing patterns of substance use in the country and highlight the need for ongoing research and intervention strategies.

Another noteworthy development was the FDA’s decision to regulate 7-OH, a psychoactive compound derived from the kratom plant. This move raised concerns about the safety and regulation of kratom products in the U.S. and sparked discussions about the potential impact on public health.

See also  Museums Cautiously Optimistic as Some Federal Grants Reinstated

In a candid conversation with leading nutrition scientist Kevin Hall, insights were shared on the administration’s food policies and the importance of evidence-based research in shaping public health initiatives. Hall’s perspective on ultra-processed foods and artificial additives shed light on the complexities of nutritional science and the challenges of navigating food policy decisions.

In a Lancet analysis, it was revealed that 60% of liver cancers globally are preventable by addressing risk factors such as viral hepatitis, alcohol consumption, and liver conditions caused by excess fat. This finding underscores the importance of preventive measures in reducing the burden of liver cancer worldwide.

Lastly, discussions about President Trump’s executive order on AI highlighted concerns about the potential impact on health-related applications of artificial intelligence. Experts raised questions about the implications of the order and its implications for future developments in healthcare technology.

Overall, these recent developments in health and medicine underscore the importance of staying informed and engaged in ongoing discussions about public health policies, research findings, and regulatory decisions. By staying informed and involved, we can contribute to a healthier and more vibrant future for all.

TAGGED:GrantsNIHPrasadSNAPedVinay
Share This Article
Twitter Email Copy Link Print
Previous Article Epstein Victim Virginia Giuffre First Met Ghislaine at Mar-a-Lago Epstein Victim Virginia Giuffre First Met Ghislaine at Mar-a-Lago
Next Article The Naked Gun Review: Charged With Man’s Laughter The Naked Gun Review: Charged With Man’s Laughter
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *


The reCAPTCHA verification period has expired. Please reload the page.

Popular Posts

CBS Stirs Up New Mix For Venerable ‘Evening News’

CBS Evening News Revamps Format to Focus on Depth and Enterprise Reporting CBS is once…

January 27, 2025

If You’d Invested $1,000 in Costco Stock 10 Years Ago, Here’s How Much You’d Have Today

Costco Wholesale (NASDAQ: COST) has been on a winning streak in 2026, with share prices…

March 21, 2026

‘It’s Nice to Be Here’

Eric Dane made a triumphant return to the spotlight at Amazon MGM’s premiere of “Countdown”…

June 18, 2025

FCC Takes Aim at Political Interviews on Late-Night and Daytime Shows

The Federal Communications Commission (FCC) has recently issued a statement targeting late-night and daytime talk…

January 21, 2026

Donald Trump mounts lobbying effort to pass US spending bill

Unlock the White House Watch newsletter for free If you’re looking for a comprehensive guide…

June 27, 2025

You Might Also Like

STAT+: RFK Jr.’s screen time warning
Health and Wellness

STAT+: RFK Jr.’s screen time warning

May 21, 2026
The New Surgeon General Advisory On The Harms Of Screen Use— Here’s What The Science Says About Risks And Benefits
Health and Wellness

The New Surgeon General Advisory On The Harms Of Screen Use— Here’s What The Science Says About Risks And Benefits

May 21, 2026
After decades of research, in utero gene therapy nears first trial
Health and Wellness

After decades of research, in utero gene therapy nears first trial

May 20, 2026
Inside Incyte’s 0 Million AI For Drug Development Deal
Health and Wellness

Inside Incyte’s $120 Million AI For Drug Development Deal

May 20, 2026
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?